Cytiva, now joined by the life sciences division of Pall Corporation, is a global biotechnology leader committed to supporting customers in the discovery and commercialization of next-generation therapeutics. We provide specialized technical expertise along with a comprehensive range of tools, technologies, and services to support the development, manufacturing, and delivery of innovative treatments to patients.

As part of Danaher—a global leader in science and technology—we work alongside other Danaher companies to accelerate scientific and technological advancements that enhance human health.